SOURCE: Imaging3, Inc.

March 30, 2010 07:00 ET

Imaging3 Announces Investor Forum

BURBANK, CA--(Marketwire - March 30, 2010) -  Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Tuesday, March 30, 2010 the Imaging3 Investor Forum will be open for Investor questions and comments. The purpose of the Investor Forum is to provide Imaging3 investors a platform in which they can leave their questions about Imaging3, Inc., the Dominion Volumetric Imaging Scanner (DViS), or other relevant topics.

Based on Investor interests, we will prepare a video that will answer questions left by visitors to the Forum. Presently, we plan on doing one video per week. The frequency of video updates is subject to change depending on factors such as the diversity and quantity of questions. 

Also, based on Shareholder comments and suggestions, we expect this format to evolve. We will notify Investors of any changes to the site or other important news though the company's e-mail Newsletter. Anyone who is not on this mailing list but would like to be, please follow this link to the sign up form on the Imaging3 web site

If you have any questions, please feel free to contact us by e-mail or directly by calling (800) 900-9729.

About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at for more information.

Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.

Contact Information